Samil PwC: "Field Application Is Key for Korean Medtech"

There are opinions that for South Korea's medtech (medical + technology) industry to advance, it is necessary to go beyond technology development and establish concrete action plans for application in the medical field.

According to Samil PwC's recent report, "Global Healthcare Restructuring: The Evolution of Medtech and Strategic Choices for K-Medtech," the domestic medtech industry possesses excellent technological competitiveness and medical infrastructure, but its structural limitations are clear. A representative from Samil PwC stated, "There are still many constraints in terms of the diffusion structure after hospital adoption, alignment with the reimbursement and compensation system, and global commercialization capabilities."

원본보기 아이콘

The report emphasized that five key action tasks are necessary as response strategies for companies engaged in medtech: shifting to a strategy focused on the full cycle of medical services, building an ecosystem that connects hospitals, insurers, and the government, securing evidence for compensation based on clinical and economic value, designing a business structure aligned with global standards, and evolving into data-driven platforms.

The report also analyzed that investors are focusing more on companies with scalable implementation structures in medical settings rather than those with a single product. For example, in the medtech mergers and acquisitions (M&A) market, areas where data-driven technologies and medical services are combined-such as AI-based diagnostics, surgical and therapeutic support robots, digital therapeutics, and patient management-are particularly active.

Seo Yongbeom, Biohealthcare Industry Leader (Partner) at Samil PwC, advised, "In the medtech industry, the process of actual application and diffusion in the medical field after technology development is becoming increasingly important," adding, "Korean medtech companies also need to review their business structures and global expansion strategies from the perspective of the entire medical service cycle."

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.